Related Experiment Video
Updated: Oct 19, 2025

Dissection of the Transversus Abdominis Muscle for Whole-mount Neuromuscular Junction Analysis
Published on: January 11, 2014
Recent advances in nemaline myopathy.
Jenni Laitila1, Carina Wallgren-Pettersson2
1The Folkhälsan Institute of Genetics, Folkhälsan Research Center, Helsinki, Finland; Department of Medical Genetics, Medicum, University of Helsinki, Finland; Department of Biomedical Sciences, University of Copenhagen, Denmark.
Nemaline myopathies, a group of congenital muscle disorders, cause muscle weakness and distinctive nemaline rods. This review proposes a new classification and discusses pathogenesis and therapeutic targets.
Area of Science:
- Neurology
- Genetics
- Muscle Biology
Background:
- Nemaline myopathies are congenital myopathies characterized by muscle weakness and nemaline rods on biopsy.
- Over twelve genes encoding thin filament proteins are implicated, leading to diverse clinical and histological presentations.
Purpose of the Study:
- To propose a renewed clinical classification for nemaline myopathies.
- To summarize current knowledge on the pathogenesis of nemaline myopathies linked to specific gene mutations.
- To explore potential therapeutic strategies based on pathogenetic mechanisms.
Main Methods:
- Literature review and synthesis of existing data on nemaline myopathies.
- Analysis of genotype-phenotype correlations.
- Review of pathogenetic mechanisms and potential therapeutic targets.
Main Results:
- A revised clinical classification for nemaline myopathies is proposed.
- Detailed summaries of pathogenesis associated with mutations in causative genes are presented.
- Perspectives on therapeutic interventions targeting specific pathogenetic pathways are discussed.
Conclusions:
- A unified approach to classification and understanding pathogenesis is crucial for nemaline myopathies.
- Targeting specific molecular pathways offers potential for future therapeutic development.
- Further research into genotype-phenotype relationships and pathogenetic mechanisms is warranted.
More Related Videos
06:35In Vivo Electrophysiological Measurement of Compound Muscle Action Potential from the Forelimbs in Mouse Models of Motor Neuron Degeneration
Published on: June 15, 2018
09:07Electrophysiological Motor Unit Number Estimation MUNE Measuring Compound Muscle Action Potential CMAP in Mouse Hindlimb Muscles
Published on: September 25, 2015